Cargando…
A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2
Intracellular antibodies are tools that can be used directly for target validation by interfering with properties like protein-protein interactions. An alternative use of intracellular antibodies in drug discovery is developing small-molecule surrogates using antibody-derived (Abd) technology. We pr...
Autores principales: | Bery, Nicolas, Bataille, Carole J.R., Russell, Angela, Hayes, Angela, Raynaud, Florence, Milhas, Sabine, Anand, Sneha, Tulmin, Hanna, Miller, Ami, Rabbitts, Terence H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034850/ https://www.ncbi.nlm.nih.gov/pubmed/33837087 http://dx.doi.org/10.1126/sciadv.abg1950 |
Ejemplares similares
-
Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds
por: Canning, Peter, et al.
Publicado: (2021) -
BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
por: Bery, Nicolas, et al.
Publicado: (2018) -
Correction: BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions
por: Bery, Nicolas, et al.
Publicado: (2018) -
LMO2 at 25 years: a paradigm of chromosomal translocation proteins
por: Chambers, Jennifer, et al.
Publicado: (2015) -
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
por: Quevedo, Camilo E., et al.
Publicado: (2018)